Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares WHO classification of haematolymphoid tumours, fifth edition: lymphoid neoplasms, R-CHOP (lymphoma chemoimmunotherapy), Autologous stem cell transplant (high-dose therapy), CD20 and the tag subtype-page.
Shares TP53-mutated (p53-abnormal), Autologous stem cell transplant (high-dose therapy), Allogeneic stem cell transplantation, TP53 and the tag subtype-page.
Shares TP53-mutated (p53-abnormal), Allogeneic stem cell transplantation, Venetoclax, TP53 and the tag subtype-page.
Shares WHO classification of haematolymphoid tumours, fifth edition: lymphoid neoplasms, Ibrutinib, Rituximab and the tag subtype-page.
Shares TP53-mutated (p53-abnormal), Allogeneic stem cell transplantation, Venetoclax, TP53 and the tag subtype-page.
Shares CDKN2A/B homozygous deletion, PET/CT and the tag subtype-page.
Shares Allogeneic stem cell transplantation, Venetoclax, Cyclophosphamide and the tag subtype-page.
Shares Autologous stem cell transplant (high-dose therapy), Allogeneic stem cell transplantation and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.